Skip to main content

Table 4 Correlation of IMT with clinical and laboratory characteristics

From: Methotrexate use, not interleukin 33, is associated with lower carotid intima-media thickness in patients with rheumatoid arthritis

Variable

Coefficienta

p-value

Age (years)

0.613

< 0.001

Disease length (years)

0.224

0.024

Age at onset of symptoms (years)

0.334

0.001

Time since onset of symptoms to 1st rheumatology visit (years)

0.204

0.040

Fasting glucose (mg/dL)

0.263

0.008

SAP (mmHg)

0.282

0.004

Global Cardiovascular Risk Score

0.591

< 0.001

Current prednisone daily dose

−0.205

0.039

IL-33 (pg/mL)b

−0.77

0.439

IL-33 (pg/mL)c

−0.035

0.775

sST2 (pg/mL)d

0.002

0.981

IL-33/sST2**

− 0.071

0.566

  1. aSpearman’s correlation coefficient
  2. IMT intima-media thickness, IQR interquartile range, SD standard deviation, CRP C-reactive protein; and SAP systemic arterial pressure
  3. blevels below the limit of detection were considered as zero
  4. conly considering the 68 participants with levels above the limit of detection
  5. ddata from the 101 participants with detectable levels
  6. eIL-33-to-sST2 ratio
Back to article page

Advances in Rheumatology

ISSN: 2523-3106